KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Debt Ratio (2017 - 2020)

Historic Debt Ratio for Xenon Pharmaceuticals (XENE) over the last 4 years, with Q1 2020 value amounting to 0.13.

  • Xenon Pharmaceuticals' Debt Ratio rose 7.74% to 0.13 in Q1 2020 from the same period last year, while for Mar 2020 it was 0.13, marking a year-over-year increase of 7.74%. This contributed to the annual value of 0.11 for FY2019, which is N/A changed from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Debt Ratio stood at 0.13 for Q1 2020, which was up 7.74% from 0.11 recorded in Q4 2019.
  • In the past 5 years, Xenon Pharmaceuticals' Debt Ratio ranged from a high of 0.18 in Q1 2018 and a low of 0.11 during Q4 2019
  • In the last 4 years, Xenon Pharmaceuticals' Debt Ratio had a median value of 0.14 in 2019 and averaged 0.14.
  • Examining YoY changes over the last 5 years, Xenon Pharmaceuticals' Debt Ratio showed a top increase of 3647.28% in 2019 and a maximum decrease of 2741.93% in 2019.
  • Over the past 4 years, Xenon Pharmaceuticals' Debt Ratio (Quarter) stood at 0.15 in 2017, then fell by 22.65% to 0.11 in 2018, then decreased by 7.8% to 0.11 in 2019, then increased by 25.71% to 0.13 in 2020.
  • Its last three reported values are 0.13 in Q1 2020, 0.11 for Q4 2019, and 0.16 during Q3 2019.